Clinuvel Pharmaceuticals Ltd logo

Clinuvel Pharmaceuticals Ltd (UR9)

Market Open
15 Jun, 15:05
XSTU XSTU
5. 52
+0.21
+3.9157%
- Market Cap
- P/E Ratio
- Div Yield
600 Volume
- Eps
5.31
Previous Close
Add Transaction
Day Range
5.52 5.7
Year Range
4.93 8.07
Want to track UR9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Clinuvel Pharmaceuticals Ltd logo
UR9 Clinuvel Pharmaceuticals Ltd
24 Feb 2026
-
-
Clinuvel Pharmaceuticals Ltd logo
UR9 Clinuvel Pharmaceuticals Ltd
4 Sep 2025
-
-
Clinuvel Pharmaceuticals Ltd logo
UR9 Clinuvel Pharmaceuticals Ltd
17 Aug 2025
-
-
Clinuvel Pharmaceuticals Ltd logo
UR9 Clinuvel Pharmaceuticals Ltd
20 Feb 2025
-
-
Clinuvel Pharmaceuticals Ltd logo
UR9 Clinuvel Pharmaceuticals Ltd
26 Aug 2024
-
-

UR9 Earnings Reports FAQ

What is the earnings per share (EPS) for UR9?

EPS data for UR9 is currently not available, as Clinuvel Pharmaceuticals Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Clinuvel Pharmaceuticals Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Clinuvel Pharmaceuticals Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Clinuvel Pharmaceuticals Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for UR9 at this time, as Clinuvel Pharmaceuticals Ltd has no recent EPS data to calculate it.